Reset filters
  • 27 March 2012

Antiretroviral rollout provides a model for efforts to expand hepatitis C treatment and care in resource-limited settings

Read the article
  • 14 March 2012

Studies look at interactions between new hepatitis C drugs and HIV antiretrovirals

Read the article
  • 7 March 2012

GS-7977 plus ribavirin rapidly suppresses HCV but most patients relapse

Read the article
Presenter Edward Gane
  • 7 March 2012

Telaprevir and boceprevir boost sustained response rates for HIV/HCV coinfected

Read the article
Prof. Douglas Dieterich (left) and Prof. Mark Sulkowski (right).
  • 20 January 2012

Common side-effects of hepatitis C protease inhibitors: clinical management advice published

Read the article
  • 29 December 2011

Early guidance on use of hepatitis C protease inhibitors in HIV-co-infected patients

Read the article
  • 4 November 2011

Persistence of very low levels of virus increase risk of relapse after hepatitis C therapy

Read the article
  • 22 October 2011

Hepatitis C drug boceprevir achieves 70% viral suppression rate in HIV co-infected people within 24 weeks

Read the article
  • 14 October 2011

Gene variant that helps hepatitis C treatment may hinder HIV treatment

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.